Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis

Clinical Infectious Diseases

Volumn 45, Issue 3, 2007, Pages 322-328

  Detjen, Anne K ^a,b   Keil, T ^a   Roll, S ^a   Hauer, B ^c   Mauch, H ^b   Wahn, U ^a   Magdorf, K ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^c German Central Committee Against Tuberculosis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; QUANTIFERON; T-SPOT; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; HOSPITAL; HUMAN; INCIDENCE; INFANT; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LYMPHADENITIS; MALE; MYCOBACTERIOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GERMANY; HUMANS; INCIDENCE; INFANT; INTERFERON TYPE II; MYCOBACTERIUM INFECTIONS; PATIENT SELECTION; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 34547110105     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/519266     Document Type: Article

References (37)

1. Haverkamp MH, Arend SM, Lindeboom JA, Hartwig NG, van Dissel JT. Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis 2004; 39:450-6.
2. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64:16-22.
3. Pai M, Kalantri S, Dheeda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6:413-22.
4. Pai M, Menzies D. Interferon-γ release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007; 4:74-7.
5. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364:2196-203.
6. Piana F, Codesca LR, Cavallerio P, et al. Use of a T-cell-based test for the detection of tuberculosis infection among immunocompromised patients. Eur Respir J 2006; 28:31-4.
7. Khang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon-γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293:2756-61.
8. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India. JAMA 2005; 293:2746-55.
9. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001; 163:824-8.
10. Shams H, Klucar P, Weis SE, et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005; 172:1161-8.
11. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146:340-54.
12. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367:1328-34.
13. Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28:24-30.
14. Arend SM, Thijsen SFT, Leyten EMS, et al. Comparison of two interferon-γ release assays and tuberculin-skin test for tracing TB contacts. Am J Resp Crit Care Med 2007; 175:618-27.
15. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2006. Available at: http://www.nice.org.uk. Accessed 31 March 2007.
16. Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54:49-55.
17. American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161:221-47.
18. Oxford Immunotec Web page. T SPOT-TB test manufacturer's instructions. Available at: http://www.oxfordimmunotec.com. Accessed 11 June 2007.
19. Cellestis Web page. QuantiFERON-TB Gold In-Tube test manufacturer's instructions. Available at: http://www.cellestis.com. Accessed 11 June 2007.
20. Starke JR. Interferon-γ release assays for diagnosis of tuberculosis infection in children. Pediatr Infect Dis J 2006; 25:941-2.
21. Nicol MP, Pienaar D, Wood K, et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis 2005; 40:1301-8.
22. Dogra S, Narang P, Mendiratta DK, et al. Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Inf 2007; 54:267-76.
23. Nakaoka H, Lawson L, Bertel Squire S, et al. Risk for tuberculosis among children. Emerg Infect Dis 2006; 12:1383-8.
24. Tsiouris SJ, Austin J, Toro P, et al. Results of a tuberculosis-specific IFN-γ assay in children at high risk for tuberculosis infection. Int J Tuberc Lung Dis 2006; 10:939-41.
25. Hill PC, Brookes RH, Adetifa IMO, et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 2006; 117:1542-8.
26. Robert Koch-Institut. Bericht zur epidemiologie der tuberkulose in Deutschland für 2005. Berlin, Germany: Robert Koch-Institut, 2007; 35-7. Available at: http://www.rki.de. Accessed 5 April 2007.
27. Romanus V. Mycobacterial infections in Sweden. Scand J Infect Dis Suppl 1995; 98:15-6.
28. Vu TT, Daniel SJ, Quach C. Nontuberculous mycobacteria in children: a changing pattern. J Otolaryngol 2005; 34(Suppl 1):S40-4.
29. Wiese-Posselt M, Siedler A, Rademacher A, Altmann D, Haas WH, ESPED Studiengruppe. Krankheitsbezogene daten zu infektionen mit nichttuberkulö sen mykobakterien (NTM) bei kindern und jugendlichen <15 jahren, Deutschland 2002-2004. Monatsschr Kinderheilk 2005; 152(S1):797.
30. Haimi-Cohen Y, Zeharia A, Mimouni M, Soukhman M, Amir J. Skin indurations in response to tuberculin testing in patients with nontu-berculous mycobacterial lymphadenitis. Clin Infect Dis 2001; 33: 1786-8.
31. Wang JY, Chou CH, Lee LN, et al. Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-γ. Emerg Infect Dis 2007; 13:553-8.
32. Diel R, Forssbohm M, Loytved G, et al. Empfehlungen fur die Umgebungsuntersuchungen bei Tuberkulose. Pneumologie 2007.
33. Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006; 61:616-20.
34. Franken WPJ, Timmermans JF, Prins C, et al. Mantoux vs. QuantiFERON TB Gold for detection of latent tuberculosis infection in the army. Clin Vaccine Immunol 2007; 14:477-80.
35. Porsa E, Cheng L, Seale MM, et al. Comparison of new ESAT-6/EFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol 2006; 13:53-8.
36. Doherty TM, Demissie A, Menzies D, Andersen P, Rook G, Zumla A; VACSEL Study Group. Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. J Immunol Methods 2005; 298:129-41.
37. Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005; 24:529-36.